Panitumumab [panitumumab]
topical
58
- Terms
-
Vectibix
-
ABX-EGF MAb
ABX-EGF Monoclonal Antibody
Panitumumab Antibody, Human
Vectibix
Persistent link
https://www.medvik.cz/link/D000077544
Definition
Recombinant human monoclonal antibody that binds to and inhibits the function of the EPIDERMAL GROWTH FACTOR RECEPTOR. It is used in the treatment of EGFR-expressing metastatic colorectal cancer that expresses wild-type ras gene (see GENES, RAS).
- DUI
- D000077544 MeSH Browser
- CUI
- M0484911
- CAS
- Immunoglobulin, anti-(human epidermal growth factor receptor) (human monoclonal ABX-EGF heavy chain), disulfide with human monoclonal ABX-EGF light chain, dimer
- History note
- 2019 (2005)
- Public note
- 2019; PANITUMUMAB was indexed under ANTIBODIES, MONOCLONAL 2005-2018
Allowable subheadings
- AD
- administration & dosage 6
- AE
- adverse effects 5
- AN
- analysis
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CH
- chemistry
- CL
- classification
- DE
- drug effects
- EC
- economics 1
- GE
- genetics
- HI
- history
- IM
- immunology 1
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 8
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- TU
- therapeutic use 20
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs